Pediatric Pertussis in Ambulatory Settings
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE2
Study of Isatuximab and Cemiplimab in Relapsed or Refractory Natural Killer/T-cell Lymphoid Malignancy
- Status
- COMPLETED
- Phase
- PHASE2
Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone With/Without Bortezomib in the Treatment of Newly Diagnosed Non Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years).
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
RSV Burden in Outpatient and Hospital Settings
- Status
- RECRUITING
- Phase
- NA
Development of an Assessment Tool for Health-related Quality of Life in Children and Adolescents With Pompe Disease
- Status
- COMPLETED
- Phase
- NA
Inflammatory Pathways and Cardiac Growth Factors Associated With Fabry Disease Cardiomyopathy
- Status
- UNKNOWN
- Phase
- N/A
Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE4
Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Long-term Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With Venglustat
- Status
- TERMINATED
- Phase
- PHASE3
Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence
- Status
- TERMINATED
- Phase
- PHASE4
Ultra Curto (Ultra Short) TB Prevention Therapy
- Status
- COMPLETED
- Phase
- PHASE4
Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)
- Status
- COMPLETED
- Phase
- PHASE3
Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)
- Status
- COMPLETED
- Phase
- PHASE3
Anti-PD1-antibody and Pulsed HHI for Advanced BCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Dupilumab in Japanese Patients With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Dupilumab in CRSsNP
- Status
- COMPLETED
- Phase
- PHASE3